Literature DB >> 2873411

Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas.

D Gonzalez-Barcena, N E Rangel-Garcia, P L Perez-Sanchez, C Gutierrez-Damperio, F Garcia-Carrasco, A M Comaru-Schally, A V Schally.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2873411     DOI： 10.1016/s0140-6736(86)91961-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

2.  Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines.

Authors:  Y Takeda; M J Escribano
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer.

Authors:  J J Sharma; B Razvillas; C D Stephens; S G Hilsenbeck; A Sharma; M L Rothenberg
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.

Authors:  B Szende; A Zalatnai; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.

Authors:  A Zalatnai; A V Schally
Journal:  Int J Pancreatol       Date:  1989-03

6.  Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.

Authors:  J I Paz-Bouza; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 7.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

Review 8.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 9.  Androgen influence on exocrine pancreatic cancer.

Authors:  A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1989-05

Review 10.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.